Search filters

List of works by Federico Piacentini

A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy

scientific article published on 16 February 2009

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

scientific article published on 25 May 2017

Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): ...

scientific article (publication date: December 2015)

Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer

scientific article

Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management

scientific article published on 23 July 2008

Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor

scientific article published on 2 June 2008

Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-institution analysis

scientific article published on 20 September 2012

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

scientific article published on 07 August 2019

Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.

scientific article published on 3 March 2014

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer.

scientific article published on 5 July 2016

Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial

scientific article

Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer: a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB).

scientific article published in February 2008

Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients.

scientific article

Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer

scientific article published on 8 February 2011

Metronomic Capecitabine Effectively Blocks Leptomeningeal Carcinomatosis From Breast Cancer: A Case Report and Literature Review.

scientific article published on 28 February 2017

Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?

scientific article published on 04 January 2017

Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus

scientific article published on 24 July 2018

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going

scientific article published on 15 January 2018

PIK3CA mutation in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer: association with prognosis and integration with PAM50 subtype

scientific article published on 25 August 2020

Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer

scientific article published on 09 August 2007

Post-surgical pyoderma gangrenosum of the breast: needs for early diagnosis and right therapy

scientific article published on 18 December 2018

Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

scientific article published on 12 November 2019

Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis

scientific article published on 03 March 2012

Preoperative Carboplatin–Paclitaxel–Bevacizumab in Triple-Negative Breast Cancer: Final Results of the Phase II Ca.Pa.Be Study

scientific article published on 09 January 2015

Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB Trial).

scientific article published in April 2008

Primary pulmonary cancer colliding with metastatic breast carcinoma: hitherto unreported cases of cancer-to-cancer metastasis focusing on clinical implications

scientific article published on 20 July 2011

Prognostic Factors for Breast Cancer: an Immunomorphological Update

scientific article published on 20 November 2015

Timing for starting second-line therapy in recurrent ovarian cancer

scientific article published on January 2011

Tumor Stroma Manipulation By MSC.

scientific article published on 7 March 2016

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials.

scientific article published on 13 March 2017

Paulina is supported by:

About Paulina

Help